Interestingly, our previous study demonstrated relative preservation of M1/M4 mAChRs within attention/executive, ventral visual and salience hubs as a possible criteria for cognitive responsiveness to cholinesterase inhibitor therapy in DLB [7]. This evidence concerns the gene BCHE and Lewy body dementia.